GLP-1

Plug & Play, the innovation platform, is turning its attention to companion nutrition for people taking GLP-1 weight-loss drugs, framing it as the next growth area for the microbiome and nutrition sector. As uptake of medications like Ozempic and Wegovy grows, attention is shifting to foods and supplements that help patients maintain muscle, gut health and nutrient intake while eating less.

New research indicates that close to one in six children taking GLP-1 medications, widely used for weight management and diabetes, develop nutritional deficiencies. The finding raises questions about monitoring and dietary support for young patients on these increasingly prescribed drugs, as clinicians weigh the benefits of treatment against risks of inadequate nutrient intake during childhood development.